Filed Under : 
Feb.19,2010
AFREZZA powder inhalation reduces the incidence of hypoglycemia in patients with type 1 diabetes treatments containing AFREZZATM (Insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, ultra short-acting insulin to provide glycemic control similar to insulin Standard weight loss and reduced incidence of hypoglycemia in patients with type 1 diabetes poorly controlled sugar levels in the blood, using a two-year study presented today at the …
Tags :
You can leave a response, or trackback from your own site.